Cargando…
Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan
Despite significant advances in pharmacologic approaches to treat hypertension during the last decades, hypertension- and hypertension-related organ damage are still a high health and economic burden because a large proportion of patients with hypertension do not achieve optimal blood pressure contr...
Autores principales: | Varagic, Jasmina, Punzi, Henry, Ferrario, Carlos M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251532/ https://www.ncbi.nlm.nih.gov/pubmed/25473311 http://dx.doi.org/10.2147/IBPC.S50954 |
Ejemplares similares
-
Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
por: Ishak, Jack, et al.
Publicado: (2017) -
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data
por: Giles, Thomas D., et al.
Publicado: (2017) -
Efficacy of nebivolol‐valsartan single‐pill combination in obese and nonobese patients with hypertension
por: Mende, Christian W., et al.
Publicado: (2017) -
Simultaneous Estimation of Nebivolol Hydrochloride and Valsartan using RP HPLC
por: Kokil, S. U., et al.
Publicado: (2009) -
Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date
por: Vilela-Martin, José Fernando
Publicado: (2016)